Global Blood Therapeutics is developing novel, orally-available therapeutics designed to change the treatment paradigm for chronic blood diseases. The Company is addressing severe, non-malignant blood-based diseases for which there are currently no effective cures and only extremely limited therapeutic options.

Research Grants 1 show all


$724.7K
2010

Patents 299show all

  • 48
    C07D - Heterocyclic compounds
  • 23
    A61K - Preparations for medical, dental, or toilet purposes
  • 15
    A61F - Filters implantable into blood vessels
  • 5
    A61B - Diagnosis
  • 5
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 5
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 4
    C07C - Acyclic or carbocyclic compounds
  • 3
    A61M - Devices for introducing media into, or onto, the body
  • 3
    C07B - General methods of organic chemistry
  • 3
    C22F - Changing the physical structure of non-ferrous metals and non-ferrous alloys

Clinical Trials 29show all

13Phase 38Phase 27Phase 1

SEC Filings show all


75
8-K

14
10-Q

4
10-K

1
D

1
S-1

Contact Information

South San Francisco, CA
United States